Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland.
Centro Cardiologico Monzino, IRCCS, Milano, Italy & Department of Clinical sciences and Community health, Cardiovascular Section, University of Milano, Milano, Italy.
Am Heart J. 2018 Aug;202:116-126. doi: 10.1016/j.ahj.2018.05.009. Epub 2018 May 22.
Heart failure with reduced ejection fraction (HFrEF) is common in the developed world and results in significant morbidity and mortality. Accurate risk assessment methods and prognostic variables are therefore needed to guide clinical decision making for medical therapy and surgical interventions with the ultimate goal of decreasing risk and improving health outcomes. The purpose of this review is to examine the role of cardiopulmonary exercise testing (CPET) and its most commonly used ventilatory gas exchange variables for the purpose of risk stratification and management of HFrEF. We evaluated five widely studied gas exchange variables from CPET in HFrEF patients based on nine previously used systematic criteria for biomarkers. This paper provides clinicians with a comprehensive and critical overview, class recommendations and evidence levels. Although some CPET variables met more criteria than others, evidence supporting the clinical assessment of variables beyond peak V̇O is well-established. A multi-variable approach also including the V̇-V̇CO slope and EOV is therefore recommended.
射血分数降低的心力衰竭(HFrEF)在发达国家很常见,会导致严重的发病率和死亡率。因此,需要准确的风险评估方法和预后变量来指导药物治疗和手术干预的临床决策,最终目的是降低风险并改善健康结果。本综述的目的是探讨心肺运动测试(CPET)及其最常用的通气气体交换变量在 HFrEF 风险分层和管理中的作用。我们根据之前用于生物标志物的九条系统标准,评估了 HFrEF 患者的 CPET 中五个广泛研究的气体交换变量。本文为临床医生提供了全面而关键的概述、分类建议和证据水平。虽然一些 CPET 变量比其他变量符合更多的标准,但支持评估除峰值 V̇O 以外的变量的临床证据是确凿的。因此,建议采用多变量方法,包括 V̇-V̇CO 斜率和 EOV。